- Home
- Our People
- Professor Kate Dolan
Professor Kate Dolan
Tabs
Publications related to this Person
Books
Winsley NC; Zador D; Larney S; Dolan K, 2016, Patient motivations, perceptions and experiences of opioid substitution therapy in prison, NDARC Technical Report Number 332, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/Technical%20Report%20Number%20332.pdf
Dolan K; Ezard N; Baldry E; Day C; Cubitt T; Loesch B; Mackay T; Burns L; Hodge S, 2015, Feasibility of a Managed Alcohol Program (MAP) for Sydney's Homeless, St Vincent's Hospital Sydney, Foundation for Alcohol Research and Education, Canberra, http://www.fare.org.au/wp-content/uploads/research/Feasibility-of-a-Managed-Alcohol-Program-for-Sydney%E2%80%99s-homeless.pdf
Dolan KA, 2014, Lesbian women and sexual health: The social construction of risk and susceptibility, http://dx.doi.org/10.4324/9781315785660
Larney S; Toson B; Burns LA; Dolan K, 2011, Opioid substitution treatment in prison and post-release: Effects on criminal recidivism and mortality, Original, National Drug Law Enforcement Research Fund (NDLERF), Canberra, ACT, http://www.ndlerf.gov.au/pub/Monograph_37.pdf
Dolan K, 2010, Advancing the sexual and reproductive health and human rights of prisoners living with HIV: A policy briefing, Original, The Global Network of People Living with HIV (GNP+), Amsterdam, The Netherlands, http://www.gnpplus.net/
Mathers BM; Wodak AD; Shakeshaft AP; Khoei EM; Dolan K, 2009, A rapid assessment and reponse to HIV and drug use in Mongolia, Original, National Drug and Alcohol Research Centre, Sydney, NSW, http://ndarc.med.unsw.edu.au/resource/rapid-assessment-and-response-hiv-and-drug-use-mongolia
Larney S; Dolan K, 2008, Demand reduction strategies in closed settings in China, Indonesia and Viet Nam, Original, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, Australia
Larney S; Matthers B; Dolan K, 2007, Illicit drug treatment in prison: Detoxification, drug-free units, therapeutic communities and opioid substitution treatment, Original, National Drug & Alcohol Research Centre, Randwick, NSW
Larney S; Morton P; Dolan K, 2007, Hiv Prevention, Treatment And Care In Prisons In South-East Asia, Original, National Drug and Alcohol Research Centre, University of New, Sydney, NSW, Sydney, http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/resources/TR+288-292/$file/TR290_TOC_ABSTRACT.pdf
Dolan K, 2005, Writing for Publication: The Basics, Original, National Drug & Alcohol Research Centre, Randwick, NSW
Day CA; Conroy EJ; Lowe J; Kimber J; Page J; Dolan K, 2005, Drug use and harms among rural and Metropolitan injecting drug users: Findings from the Rural Injectors Project, Original, National Drug & Alcohol Research Centre, Randwick, NSW
Black E; Dolan K; Wodak AD, 2004, Supply, demand and harm reduction strategies in Australian Prisons, Original, Australian National Council on Drugs, Canberra, ACT Australian
Dolan K; Kite B; Black E; Lowe J; Agaliotis M; MacDonald M; Aceijas C; Stimson G; .Hickman M; Valencia G, 2004, Review of injection drug users and HIV infection in prisons in developing and transitional countries.
Dolan K; Rees V; Peters R; Wodak AD, 2003, A brief cognitive behavioural intervention for alternatives to injecting: Therapist`s treatment manual, Original, National Drug & Alcohol Research Centre, Randwick, NSW
Dolan K; Shearer J; White BA; Wodak AD, 2003, A randomised controlled trial of methadone maintenance treatment in NSW prisons, Original, National Drug & Alcohol Research Centre, Randwick, NSW
Day CA; Topp LJ; Swift W; Kaye SS; Breen CL; Kimber J; Ross JE; Dolan K, 2002, Interviewer safety in the Drug and Alcohol Field: A Safety Protocol and Training Manual for Staff of the National Drug and Alcohol Research Centre, Original, National Drug & Alcohol Research Centre, Randwick, NSW
Day CA; Ross JE; White BA; Dolan K, 2002, Australian Prevalence and Estimation of Treatment Study: New South Wales Report, Original, National Drug & Alcohol Research Centre, Randwick, NSW
Rutter S; Dolan K; Wodak AD; Heilpern H, 2001, Prison-based syringe exchange a review of international research and program development. Technical Report No. 112, 112, National Drug & Alcohol Research Centre, Randwick, NSW
Rouen DA; Dolan K; Day CA; Topp LJ; Darke S; Hall WD, 2001, Changes in heroin availability in Sydney Australia in early 2001. Technical Report No. 119, 119, National Drug & Alcohol Research Centre, Randwick, NSW
Rouen DA; Dolan K; Kimber J, 2001, A review of drug detection testing and an examination of urine, hair, saliva and sweat. Technical Report No. 120, 120, National Drug & Alcohol Research Centre, Randwick, NSW
Dolan K, 2000, Surveillance and prevention of Hepatitis C infection in Australian prisons: A discussion paper, Original, National Drug & Alcohol Research Centre, Randwick, NSW
Dolan K; Topp L; MacDonald MA, 2000, NSP Needle & Syringe Programs: A Review of the Evidence, Original, Australian National council on AIDS, Hepatitis C a, Canberra
Dolan K; Topp LJ; MacDonald MA, 2000, Needle and syringe programs: a review of the evidence, Original, ANCAHRD, Canberra, ACT
Dillon PG; Dolan K, 2000, Needle and syringe programs: your questions answered, Original, ANCAHRD, Canberra, ACT
Rouen DA; Dolan K, 2000, An evaluation of a needle and syringe program information kit. Technical Report No. 102, 102, National Drug & Alcohol Research Centre, Randwick, NSW
Shearer J; Wodak AD; Mattick RP; Van Beek IA; Lewis J; Dolan K, 1999, A randomised controlled trial of the feasibility of monitoring controlled prescribing of dexamphetamine, Original, National Drug & Alcohol Research Centre, Randwick, NSW
Hando J; Hall WD; Rutter S; Dolan K, 1999, Current state of research on illicit drugs in Australia: an information document, Original, National Heratlh & Medical Research Council, Commo, Canberra, ACT, Australia
Book Chapters
Dolan K, 2020, 'Drug use', in Clinical Challenges: Focus on Nursing, pp. 98 - 114
Dolan K; Crofts N, 2013, 'A review of risk behaviours, transmission and prevention of blood borne viral infections in Australian prisons', in Drug Use in Prisons, pp. 215 - 232, http://dx.doi.org/10.4324/9781315079998-18
Dolan K; Rodas AA, 2013, 'Drug users and imprisonment', in Rahman F; Crofts N (ed.), Drug law reform in East and Southeast Asia, edn. 1, Lexington Books, United Kingdom, pp. 39 - 58, https://rowman.com/ISBN/9780739180372
Dolan K, 2012, 'Electoral context, issues, and voting for women in the 1990s', in Women and Congress: Running, Winning, and Ruling, pp. 21 - 36
Wodak AD; Ryan J; Griffiths P; van Beek I; Barratt M; Lenton S; Dolan K; Rodas AA; Noller G; Farrell M, 2012, 'Policy and practice in harm reduction in Australasia', in Pates R; Riley D (ed.), Harm Reduction in Substance Use and High-Risk Behaviour, edn. 1, Wiley-Blackwell, Chichester, UK, pp. 405 - 424, http://www.wiley.com/WileyCDA/WileyTitle/productCd-1118343352.html
Sanbonmatsu K; Dolan K, 2011, 'Gender stereotypes and gender preferences in American politics', in Improving Public Opinion Surveys: Interdisciplinary Innovation and the American National Election Studies, pp. 260 - 277
Dolan KA, 2008, 'Women voters, women candidates: Is there a gender gap in support for women candidates?', in Voting the Gender Gap, pp. 91 - 107
Dolan K, 2008, 'Women as candidates in American politics: The continuing impact of sex and gender', in Political Women and American Democracy, pp. 110 - 127, http://dx.doi.org/10.1017/CBO9780511790621.010
Dolan K, 2005, 'Injecting in Prisons', in Pates R; McBride A; Arnold K (ed.), Injecting Illicit Drugs, Blackwell Publishing Ltd, United Kingdom, pp. 69 - 81, http://dx.doi.org/10.1002/9780470776339.ch6
Abeni D; Perucci CA; Dolan K; Sangalli M, 2003, 'Prison and HIV-1 Infection among Drug Injectors', in World Health Organization: Drug Injecting and HIV Infection: Global Dimensions and Local Responses, pp. 168 - 182, http://dx.doi.org/10.4324/9780203214015-17
Dolan K, 2002, 'The Addicted Offender: Developments in British Policy and Practice', in Addiction, edn. 3, Blackwell Publishing Ltd, Oxford, England, pp. 365 - 365, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000174465400023&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Dolan K; Hall WD; Wodak AD, 1998, 'The provision of methadone within prison settings', in Methadone Maintenance Treatment and Other Opioid Replacement Therapies, edn. Original, Harwood Academic Publishers, The Netherlands, pp. 379 - 396
Dolan K, 1997, 'AIDS drugs and risk behaviour in prison: State of the art', in Harm reduction in Prison, edn. Original, Swiss Federal Office of Public Health, Bern, pp. 213 - 238
Journal articles
Hansen MA; Clemens JL; Dolan K, 2022, 'Gender Gaps, Partisan Gaps, and Cross-Pressures: An Examination of American Attitudes toward the Use of Force', Politics and Gender, vol. 18, pp. 273 - 295, http://dx.doi.org/10.1017/S1743923X20000690
Mehmandoost S; Khezri M; Mousavian G; Tavakoli F; Mehrabi F; Sharifi H; Dolan K; Shokoohi M, 2022, 'Prevalence of HIV, hepatitis B virus, and hepatitis C virus among incarcerated people in Iran: a systematic review and meta-analysis', Public Health, vol. 203, pp. 75 - 82, http://dx.doi.org/10.1016/j.puhe.2021.11.020
Bosworth RJ; Borschmann R; Altice FL; Kinner SA; Dolan K; Farrell M, 2022, 'HIV/AIDS, hepatitis and tuberculosis-related mortality among incarcerated people: a global scoping review', International Journal of Prisoner Health, vol. 18, pp. 66 - 82, http://dx.doi.org/10.1108/IJPH-02-2021-0018
Kraft P; Dolan K, 2022, 'Glass Half Full or Half Empty: Does Optimism about Women’s Representation in Elected Office Matter?', Journal of Women, Politics and Policy, http://dx.doi.org/10.1080/1554477X.2022.2081444
Kraft PW; Dolan K, 2022, 'Asking the Right Questions: A Framework for Developing Gender-Balanced Political Knowledge Batteries', Political Research Quarterly, http://dx.doi.org/10.1177/10659129221092473
Wiessing L; Kalamara E; Stone J; Altan P; van Baelen L; Fotiou A; Garcia D; Goulao J; Guarita B; Hope V; Jauffret-Roustide M; Jurgelaitienė L; Kåberg M; Kamarulzaman A; Lemsalu L; Kivite-Urtane A; Kolarić B; Montanari L; Rosińska M; Sava L; Horváth I; Seyler T; Sypsa V; Tarján A; Yiasemi I; Zimmermann R; Ferri M; Dolan K; Uusküla A; Vickerman P, 2021, 'Univariable associations between a history of incarceration and HIV and HCV prevalence among people who inject drugs across 17 countries in Europe 2006 to 2020 – is the precautionary principle applicable?', Eurosurveillance, vol. 26, http://dx.doi.org/10.2807/1560-7917.ES.2021.26.49.2002093
Jin X; Kinner SA; Hopkins R; Stockings E; Courtney RJ; Shakeshaft A; Petrie D; Dobbins T; Puljevic C; Chang S; Dolan K, 2021, 'A randomised controlled trial of motivational interview for relapse prevention after release from smoke-free prisons in Australia', International Journal of Prisoner Health, vol. 17, pp. 462 - 476, http://dx.doi.org/10.1108/IJPH-01-2020-0003
Shokoohi M; Karamouzian M; Dolan K; Sharifi H; Mirzazadeh A, 2021, 'Social and structural determinants of health associated with drug use patterns among female sex workers in Iran: A latent class analysis', International Journal of Drug Policy, vol. 91, http://dx.doi.org/10.1016/j.drugpo.2020.102798
Ghaderi S; Morovat B; Masoumirad R; Noori R; Saeedi Moghaddam S; Moazen B; Dolan K; Shokoohi M, 2021, 'Shining light on darkness: suicidal ideation and suicide attempt among Iranian women who do and do not use drugs', Drugs: Education, Prevention and Policy, vol. 28, pp. 349 - 356, http://dx.doi.org/10.1080/09687637.2020.1810208
Farhoudi B; SeyedAlinaghi SA; Dadras O; Tashakoriyan M; Nazari Pouya M; Gouya MM; Dolan K, 2020, 'Health service provision for disease control among prisoners: a conceptual note', Journal of Health Research, vol. 34, pp. 353 - 358, http://dx.doi.org/10.1108/JHR-04-2019-0068
Moazen B; Stöver H; Dolan K; Jahn A; Neuhann F, 2020, 'Prisoners should not be left behind in HCV research and policies', Harm Reduction Journal, vol. 17, http://dx.doi.org/10.1186/s12954-020-00379-y
Borschmann R; Tibble H; Spittal MJ; Preen D; Pirkis J; Larney S; Rosen DL; Young JT; Love AD; Altice FL; Binswanger IA; Bukten A; Butler T; Chang Z; Chen CY; Clausen T; Christensen PB; Culbert GJ; Degenhardt L; Dirkzwager AJE; Dolan K; Fazel S; Fischbacher C; Giles M; Graham L; Harding D; Huang YF; Huber F; Karaminia A; Keen C; Kouyoumdjian FG; Lim S; Møller L; Moniruzzaman A; Morenoff J; O'Moore E; Pizzicato LN; Pratt D; Proescholdbell SK; Ranapurwala SI; Shanahan ME; Shaw J; Slaunwhite A; Somers JM; Spaulding AC; Stern MF; Viner KM; Wang N; Willoughby M; Zhao B; Kinner SA, 2020, 'The Mortality after Release from Incarceration Consortium (MARIC): Protocol for a multi-national, individual participant data meta-analysis.', International Journal of Population Data Science, vol. 5, http://dx.doi.org/10.23889/ijpds.v5i1.1145
McLeod KE; Martin RE; Butler A; Young JT; Southalan L; Borschmann R; Kinner SA; Sturup-Toft S; Dirkzwager A; Dolan K; Acheampong LK; Topp SM, 2020, 'Global prison health care governance and health equity: A critical lack of evidence', American Journal of Public Health, vol. 110, pp. 303 - 308, http://dx.doi.org/10.2105/AJPH.2019.305465
Moazen B; Dolan K; Saeedi Moghaddam S; Lotfizadeh M; Duke K; Neuhann F; Stöver H; Jahn A, 2020, 'Availability, Accessibility, and Coverage of Needle and Syringe Programs in Prisons in the European Union', Epidemiologic Reviews, vol. 42, pp. 19 - 26, http://dx.doi.org/10.1093/epirev/mxaa003
Moazen B; Deckert A; Saeedi Moghaddam S; Owusu PN; Mehdipour P; Shokoohi M; Noori A; Lotfizadeh M; Bosworth R; Neuhann F; Farzadfar F; Stöver H; Dolan K, 2019, 'National and sub-national HIV/AIDS-related mortality in Iran, 1990–2015: a population-based modeling study', International Journal of STD and AIDS, vol. 30, pp. 1362 - 1372, http://dx.doi.org/10.1177/0956462419869520
Alammehrjerdi Z; Briggs NE; Biglarian A; Mokri A; Dolan K, 2019, 'A Randomized Controlled Trial of Brief Cognitive Behavioral Therapy for Regular Methamphetamine Use in Methadone Treatment', Journal of Psychoactive Drugs, vol. 51, pp. 280 - 289, http://dx.doi.org/10.1080/02791072.2019.1578445
Kwon JA; Iversen J; Law M; Dolan K; Wand H; Maher L, 2019, 'Estimating the number of people who inject drugs and syringe coverage in Australia, 2005–2016', Drug and Alcohol Dependence, vol. 197, pp. 108 - 114, http://dx.doi.org/10.1016/j.drugalcdep.2018.11.033
Haagsma JA; James SL; Castle CD; Dingels ZV; Fox JT; Hamilton EB; Liu Z; Lucchesi LR; Roberts NLS; Sylte DO; Adebayo OM; Ahmadi A; Ahmed MB; Aichour MTE; Alahdab F; Alghnam SA; Aljunid SM; Al-Raddadi RM; Alsharif U; Altirkawi K; Anjomshoa M; Antonio CAT; Appiah SCY; Aremu O; Arora A; Asayesh H; Assadi R; Awasthi A; Ayala Quintanilla BP; Balalla S; Banstola A; Barker-Collo SL; Bärnighausen TW; Bazargan-Hejazi S; Bedi N; Behzadifar M; Behzadifar M; Benjet C; Bennett DA; Bensenor IM; Bhaumik S; Bhutta ZA; Bijani A; Borges G; Borschmann R; Bose D; Boufous S; Brazinova A; Campuzano Rincon JC; Cárdenas R; Carrero JJ; Carvalho F; Castañeda-Orjuela CA; Catalá-López F; Choi JYJ; Christopher DJ; Crowe CS; Dalal K; Daryani A; Davitoiu DV; Degenhardt L; De Leo D; De Neve JW; Deribe K; Dessie GA; Deveber GA; Dharmaratne SD; Doan LP; Dolan KA; Driscoll TR; Dubey M; El-Khatib Z; Ellingsen CL; El Sayed Zaki M; Endries AY; Eskandarieh S; Faro A; Fereshtehnejad SM; Fernandes E; Filip I; Fischer F; Franklin RC; Fukumoto T; Gezae KE; Gill TK; Goulart AC; Grada A; Guo Y; Gupta R; Haghparast Bidgoli H; Haj-Mirzaian A; Haj-Mirzaian A; Hamadeh RR; Hamidi S; Haro JM; Hassankhani H; Hassen HY; Havmoeller R; Hendrie D; Henok A, 2019, 'Burden of injury along the development spectrum: Associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017', Injury Prevention, http://dx.doi.org/10.1136/injuryprev-2019-043296
Dicker D; Nguyen G; Abate D; Abate KH; Abay SM; Abbafati C; Abbasi N; Abbastabar H; Abd-Allah F; Abdela J; Abdelalim A; Abdel-Rahman O; Abdi A; Abdollahpour I; Abdulkader RS; Abdurahman AA; Abebe HT; Abebe M; Abebe Z; Abebo TA; Aboyans V; Abraha HN; Abrham AR; Abu-Raddad LJ; Abu-Rmeileh NME; Accrombessi MMK; Acharya P; Adebayo OM; Adedeji IA; Adedoyin RA; Adekanmbi V; Adetokunboh OO; Adhena BM; Adhikari TB; Adib MG; Adou AK; Adsuar JC; Afarideh M; Afshin A; Agarwal G; Aggarwal R; Aghayan SA; Agrawal S; Agrawal A; Ahmadi M; Ahmadi A; Ahmadieh H; Ahmed MLCB; Ahmed S; Ahmed MB; Aichour AN; Aichour I; Aichour MTE; Akanda AS; Akbari ME; Akibu M; Akinyemi RO; Akinyemiju T; Akseer N; Alahdab F; Al-Aly Z; Alam K; Alebel A; Aleman AV; Alene KA; Al-Eyadhy A; Ali R; Alijanzadeh M; Alizadeh-Navaei R; Aljunid SM; Alkerwi A; Alla F; Allebeck P; Allen CA; Alonso J; Al-Raddadi RM; Alsharif U; Altirkawi K; Alvis-Guzman N; Amare AT; Amini E; Ammar W; Amoako YA; Anber NH; Andrei CL; Androudi S; Animut MD; Anjomshoa M; Anlay DZ; Ansari H; Ansariadi A; Ansha MG; Antonio CAT; Appiah SCY; Aremu O; Areri HA; Ärnlöv J; Arora M; Artaman A; Aryal KK, 2018, 'Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: A systematic analysis for the Global Burden of Disease Study 2017', The Lancet, vol. 392, pp. 1684 - 1735, http://dx.doi.org/10.1016/S0140-6736(18)31891-9
Murray CJL; Callender CSKH; Kulikoff XR; Srinivasan V; Abate D; Abate KH; Abay SM; Abbasi N; Abbastabar H; Abdela J; Abdelalim A; Abdel-Rahman O; Abdi A; Abdoli N; Abdollahpour I; Abdulkader RS; Abebe HT; Abebe M; Abebe Z; Abebo TA; Abejie AN; Aboyans V; Abraha HN; Abreu DMX; Abrham AR; Abu-Raddad LJ; Abu-Rmeileh NME; Accrombessi MMK; Acharya P; Adamu AA; Adebayo OM; Adedeji IA; Adekanmbi V; Adetokunboh OO; Adhena BM; Adhikari TB; Adib MG; Adou AK; Adsuar JC; Afarideh M; Afshin A; Agarwal G; Agesa KM; Aghayan SA; Agrawal S; Ahmadi A; Ahmadi M; Ahmed MB; Ahmed S; Aichour AN; Aichour I; Aichour MTE; Akanda AS; Akbari ME; Akibu M; Akinyemi RO; Akinyemiju T; Akseer N; Alahdab F; Al-Aly Z; Alam K; Alebel A; Aleman AV; Alene KA; Al-Eyadhy A; Ali R; Alijanzadeh M; Alizadeh-Navaei R; Aljunid SM; Alkerwi A; Alla F; Allebeck P; Almasi A; Alonso J; Al-Raddadi RM; Alsharif U; Altirkawi K; Alvis-Guzman N; Amare AT; Ammar W; Anber NH; Andrei CL; Androudi S; Animut MD; Ansari H; Ansha MG; Antonio CAT; Appiah SCY; Aremu O; Areri HA; Arian N; Ärnlöv J; Artaman A; Aryal KK; Asayesh H; Asfaw ET; Asgedom SW; Assadi R; Atey TMM; Atique S, 2018, 'Population and fertility by age and sex for 195 countries and territories, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017', The Lancet, vol. 392, pp. 1995 - 2051, http://dx.doi.org/10.1016/S0140-6736(18)32278-5
Jin X; Kinner SA; Hopkins R; Stockings E; Courtney RJ; Shakeshaft A; Petrie D; Dobbins T; Dolan K, 2018, 'Brief intervention on Smoking, Nutrition, Alcohol and Physical (SNAP) inactivity for smoking relapse prevention after release from smoke-free prisons: A study protocol for a multicentre, investigator-blinded, randomised controlled trial', BMJ Open, vol. 8, http://dx.doi.org/10.1136/bmjopen-2017-021326
Khoei EM; Jamshidimanesh M; Emamian MH; Sheikhan F; Dolan K; Brady KT, 2018, 'Veiled truths: Iranian women and risky sexual behavior in the context of substance use', Journal of Reproduction and Infertility, vol. 19, pp. 237 - 246
Ezard N; Dunlop A; Hall M; Ali R; McKetin R; Bruno R; Phung N; Carr A; White J; Clifford B; Liu Z; Shanahan M; Dolan K; Baker AL; Lintzeris N, 2018, 'LiMA: A study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence', BMJ Open, vol. 8, http://dx.doi.org/10.1136/bmjopen-2017-020723
Fullman N; Yearwood J; Abay SM; Abbafati C; Abd-Allah F; Abdela J; Abdelalim A; Abebe Z; Abebo TA; Aboyans V; Abraha HN; Abreu DMX; Abu-Raddad LJ; Adane AA; Adedoyin RA; Adetokunboh O; Adhikari TB; Afarideh M; Afshin A; Agarwal G; Agius D; Agrawal A; Agrawal S; Ahmad Kiadaliri A; Aichour MTE; Akibu M; Akinyemi RO; Akinyemiju TF; Akseer N; Al Lami FH; Alahdab F; Al-Aly Z; Alam K; Alam T; Alasfoor D; Albittar MI; Alene KA; Al-Eyadhy A; Ali SD; Alijanzadeh M; Aljunid SM; Alkerwi A; Alla F; Allebeck P; Allen C; Alomari MA; Al-Raddadi R; Alsharif U; Altirkawi KA; Alvis-Guzman N; Amare AT; Amenu K; Ammar W; Amoako YA; Anber N; Andrei CL; Androudi S; Antonio CAT; Araújo VEM; Aremu O; Ärnlöv J; Artaman A; Aryal KK; Asayesh H; Asfaw ET; Asgedom SW; Asghar RJ; Ashebir MM; Asseffa NA; Atey TM; Atre SR; Atteraya MS; Avila-Burgos L; Avokpaho EFGA; Awasthi A; Ayala Quintanilla BP; Ayalew AA; Ayele HT; Ayer R; Ayuk TB; Azzopardi P; Azzopardi-Muscat N; Babalola TK; Badali H; Badawi A; Banach M; Banerjee A; Banstola A; Barber RM; Barboza MA; Barker-Collo SL; Bärnighausen T; Barquera S; Barrero LH; Bassat Q; Basu S; Baune BT; Bazargan-Hejazi S; Bedi N; Beghi E, 2018, 'Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: A systematic analysis from the Global Burden of Disease Study 2016', The Lancet, vol. 391, pp. 2236 - 2271, http://dx.doi.org/10.1016/S0140-6736(18)30994-2
Spaulding AC; Eldridge GD; Chico CE; Morisseau N; Drobeniuc A; Fils-Aime R; Day C; Hopkins R; Jin X; Chen J; Dolan KA, 2018, 'Smoking in Correctional Settings Worldwide: Prevalence, Bans, and Interventions', Epidemiologic Reviews, vol. 40, pp. 82 - 95, http://dx.doi.org/10.1093/epirev/mxy005
Ndeffo-Mbah ML; Vigliotti VS; Skrip LA; Dolan K; Galvani AP, 2018, 'Dynamic Models of Infectious Disease Transmission in Prisons and the General Population', Epidemiologic Reviews, vol. 40, pp. 40 - 57, http://dx.doi.org/10.1093/epirev/mxx014
Moazen B; Saeedi Moghaddam S; Silbernagl MA; Lotfizadeh M; Bosworth RJ; Alammehrjerdi Z; Kinner SA; Wirtz AL; Bärnighausen TW; Stöver HJ; Dolan KA, 2018, 'Prevalence of Drug Injection, Sexual Activity, Tattooing, and Piercing among Prison Inmates', Epidemiologic Reviews, vol. 40, pp. 58 - 69, http://dx.doi.org/10.1093/epirev/mxy002
Wirtz AL; Yeh PT; Flath NL; Beyrer C; Dolan K, 2018, 'HIV and Viral Hepatitis among Imprisoned Key Populations', Epidemiologic Reviews, vol. 40, pp. 12 - 26, http://dx.doi.org/10.1093/epirev/mxy003
Cunningham EB; Hajarizadeh B; Amin J; Bretana N; Dore GJ; Degenhardt L; Larney S; Luciani F; Lloyd AR; Grebely J, 2018, 'Longitudinal injecting risk behaviours among people with a history of injecting drug use in an Australian prison setting: The HITS-p study', International Journal of Drug Policy, vol. 54, pp. 18 - 25, http://dx.doi.org/10.1016/j.drugpo.2017.12.013
Ezard N; Cecilio ME; Clifford B; Baldry E; Burns L; Day CA; Shanahan M; Dolan K, 2018, 'A managed alcohol program in Sydney, Australia: Acceptability, cost-savings and non-beverage alcohol use', Drug and Alcohol Review, vol. 37, pp. S184 - S194, http://dx.doi.org/10.1111/dar.12702
Kinner SA; Snow K; Wirtz AL; Altice FL; Beyrer C; Dolan K, 2018, 'Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review', Journal of Adolescent Health, vol. 62, pp. S18 - S26, http://dx.doi.org/10.1016/j.jadohealth.2017.09.030
Alammehrjerdi Z; Ezard N; Dolan K, 2018, 'Methamphetamine dependence in methadone treatment services in Iran: the first literature review of a new health concern', Asian Journal of Psychiatry, vol. 31, pp. 49 - 55, http://dx.doi.org/10.1016/j.ajp.2018.01.001
Alammehrjerdi Z; Dolan K, 2018, 'Characteristics of Iranian female methadone patients with regular methamphetamine use', Eastern Mediterranean Health Journal, vol. 24, http://dx.doi.org/10.26719/emhj.19.004
Moazen B; Hajizadeh S; Nedjat S; Setayesh HR; Mohraz M; Gouya MM; Dolan K, 2017, 'Determinants of consistent condom use among Iranians living with HIV/AIDS: Implication for prevention', International Journal of High Risk Behaviors and Addiction, vol. 6, http://dx.doi.org/10.5812/ijhrba.63237
Cunningham EB; Hajarizadeh B; Bretana NA; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Dolan K; Lloyd AR; Grebely J; Haber P; Rawlinson W; Treloar C; Maher L, 2017, 'Ongoing incident hepatitis C virus infection among people with a history of injecting drug use in an Australian prison setting, 2005-2014: The HITS-p study', Journal of Viral Hepatitis, vol. 24, pp. 733 - 741, http://dx.doi.org/10.1111/jvh.12701
Hopkins R; Dolan KA, 2017, 'Trends in cancer incidence and survival for indigenous and non-indigenous people in the Northern Territory', Medical Journal of Australia, vol. 207, pp. 46 - 46.e1, http://dx.doi.org/10.5694/mja16.01390
Alammehrjerdi Z; Massah O; Farhoudian A; Shishehgar S; Moradi A; Dolan K, 2017, 'Opioid Use among Women on a Stable Methadone Dose', Iranian Journal of Psychiatry and Behavioral Sciences, vol. 11, http://dx.doi.org/10.5812/ijpbs.9867
Larney S; Zador D; Sindicich N; Dolan K, 2017, 'A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia', Drug and Alcohol Review, vol. 36, pp. 305 - 310, http://dx.doi.org/10.1111/dar.12442
Wiessing L; Ferri M; Běláčková V; Carrieri P; Friedman SR; Folch C; Dolan K; Galvin B; Vickerman P; Lazarus JV; Mravčík V; Kretzschmar M; Sypsa V; Sarasa-Renedo A; Uusküla A; Paraskevis D; Mendão L; Rossi D; van Gelder N; Mitcheson L; Paoli L; Gomez CD; Milhet M; Dascalu N; Knight J; Hay G; Kalamara E; Simon R; Comiskey C; Rossi C; Griffiths P; Molinaro S; Franchini M; Siciliano V; Benedetti E; Perduca M; Ylli A; Anta GB; Bravo Portela MJ; Indave I; Rácz J; Zábranskỳ T; Štefunková M; Dávila PF; Salekesin M; Vorobjov S; Dan M; Fierbinteanu C; Popescu D; Verdes L; Abagiu AO; Hatzakis A; Moudatsou M; Antypas T; Cadet-Tairou A; Collins AM; Liddell D, 2017, 'Monitoring quality and coverage of harm reduction services for people who use drugs: A consensus study', Harm Reduction Journal, vol. 14, http://dx.doi.org/10.1186/s12954-017-0141-6
Clark N; Dolan K; Farabee D, 2017, 'Public health alternatives to incarceration for drug offenders', Eastern Mediterranean Health Journal, vol. 23, pp. 222 - 230, http://dx.doi.org/10.26719/2017.23.3.222
Alammehrjerdi Z; Ezard N; Clare P; Dolan K, 2017, 'Methamphetamine use disorder untreated among women in methadone treatment in Iran', Iranian Journal of Psychiatry and Behavioral Sciences, vol. 11, http://dx.doi.org/10.5812/ijpbs.7861
Alammehrjerdi Z; Massah O; Farhoudian A; Shishehgar S; Moradi A; Dolan K, 2017, 'Therapeutic community program for opioid-dependent treatment seekers', Iranian Journal of Psychiatry and Behavioral Sciences, vol. 11, http://dx.doi.org/10.5812/ijpbs.9892
Keoshkerian E; Hunter M; Cameron B; Nguyen N; Sugden P; Bull R; Zekry A; Maher L; Seddiki N; Zaunders J; Kelleher A; Lloyd AR; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Luciani F, 2016, 'Hepatitis C-specific effector and regulatory CD4 T-cell responses are associated with the outcomes of primary infection', Journal of Viral Hepatitis, vol. 23, pp. 985 - 993, http://dx.doi.org/10.1111/jvh.12576
Alammehrjerdi Z; Ezard N; Clare P; Dolan K, 2016, 'Methamphetamine Use Disorder Untreated among Women in Methadone Treatment in Iran', Iranian Journal of Psychiatry and Behavioral Sciences, vol. In Press, http://dx.doi.org/10.17795/ijpbs-7861
Larney S; Lai W; Dolan K; Zador D, 2016, 'Monitoring a Prison Opioid Treatment Program Over a Period of Change to Clinical Governance Arrangements, 2007–2013', Journal of Substance Abuse Treatment, vol. 70, pp. 58 - 63, http://dx.doi.org/10.1016/j.jsat.2016.08.001
Altice FL; Azbel L; Stone J; Brooks-Pollock E; Smyrnov P; Dvoriak S; Taxman FS; El-Bassel N; Martin NK; Booth R; Stöver H; Dolan K; Vickerman P, 2016, 'The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia', The Lancet, vol. 388, pp. 1228 - 1248, http://dx.doi.org/10.1016/S0140-6736(16)30856-X
Rubenstein LS; Amon JJ; McLemore M; Eba P; Dolan K; Lines R; Beyrer C, 2016, 'HIV, prisoners, and human rights', The Lancet, vol. 388, pp. 1202 - 1214, http://dx.doi.org/10.1016/S0140-6736(16)30663-8
Beyrer C; Kamarulzaman A; McKee M, 2016, 'Prisoners, prisons, and HIV: time for reform', LANCET, vol. 388, pp. 1033 - 1035, http://dx.doi.org/10.1016/S0140-6736(16)30829-7
Dolan K; Wirtz AL; Moazen B; Ndeffo-mbah M; Galvani A; Kinner SA; Courtney R; McKee M; Amon JJ; Maher L; Hellard M; Beyrer C; Altice FL, 2016, 'Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees', The Lancet, vol. 388, pp. 1089 - 1102, http://dx.doi.org/10.1016/S0140-6736(16)30466-4
Kamarulzaman A; Reid SE; Schwitters A; Wiessing L; El-Bassel N; Dolan K; Moazen B; Wirtz AL; Verster A; Altice FL, 2016, 'Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners', The Lancet, vol. 388, pp. 1115 - 1126, http://dx.doi.org/10.1016/S0140-6736(16)30769-3
Moradi1 A; Alammehrjerdi Z; Amini-Lari M; Daneshmand R; Zarghami M; Dolan K, 2016, 'HIV responses in arab states on the southern persian gulf border: The first review', Iranian Journal of Psychiatry and Behavioral Sciences, vol. 10, http://dx.doi.org/10.17795/ijpbs-5392
Alam-Mehrjerdi Z; Daneshmand R; Samiei M; Samadi R; Abdollahi M; Dolan K, 2016, 'Women-only drug treatment services and needs in Iran: the first review of current literature (vol 24, 3, 2016)', DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 24, http://dx.doi.org/10.1186/s40199-016-0157-6
beyrer C; Dolan K, 2016, 'HIV prison', Lancet
Walker MR; Li H; Teutsch S; Betz-Stablein B; Luciani F; Lloyd AR; Bull RA, 2016, 'Incident hepatitis c virus genotype distribution and multiple infection in australian prisons', Journal of Clinical Microbiology, vol. 54, pp. 1855 - 1861, http://dx.doi.org/10.1128/JCM.00287-16
Mina MM; Cameron B; Luciani F; Vollmer-Conna U; Lloyd AR, 2016, 'Natural killer cells in highly exposed hepatitis C-seronegative injecting drug users', Journal of Viral Hepatitis, vol. 23, pp. 464 - 472, http://dx.doi.org/10.1111/jvh.12511
Lamoury FMJ; Hajarizadeh B; Keoshkerian E; Feld JJ; Amin J; Teutsch S; Matthews GV; Hellard M; Dore GJ; Lloyd AR; Applegate TL; Grebely J, 2016, 'HIV infection is associated with higher levels of monocyte chemoattractant protein-1 and eotaxin among people with recent hepatitis C virus infection', BMC Infectious Diseases, vol. 16, http://dx.doi.org/10.1186/s12879-016-1567-2
Doyle JS; Grebely J; Spelman T; Alavi M; Matthews GV; Thompson AJ; Dore GJ; Hellard ME; Kaldor J; Marks P; Lloyd A; Haber P; French R; White P; Rawlinson W; Day C; Van Beek I; McCaughan G; Madden A; Dolan K; Farrell G; Crofts N; Sievert W; Baker D, 2016, 'Quality of life and social functioning during treatment of recent hepatitis C infection: A multi-centre prospective cohort', PLoS ONE, vol. 11, http://dx.doi.org/10.1371/journal.pone.0150655
Alam-Mehrjerdi Z; Noori R; Dolan K, 2016, 'Opioid use, treatment and harm reduction services: The first report from the Persian Gulf region', Journal of Substance Use, vol. 21, pp. 217 - 223, http://dx.doi.org/10.3109/14659891.2014.966344
Shahbazi M; Moazen B; Rezaei F; Shokoohi M; Farnia M; Moradi G; Dolan K, 2016, 'Views of Iranian prison staff towards needle-exchange program in prison', Drugs: Education, Prevention and Policy, vol. 23, pp. 113 - 119, http://dx.doi.org/10.3109/09687637.2016.1149147
Alam-Mehrjerdi Z; Daneshmand R; Samiei M; Samadi R; Abdollahi M; Dolan K, 2016, 'Women-only drug treatment services and needs in Iran: The first review of current literature', DARU, Journal of Pharmaceutical Sciences, vol. 24, http://dx.doi.org/10.1186/s40199-016-0141-1
Noori R; Farhoudian A; Naranjiha H; Farhadi MH; Dolan K; Khoddami-Vishteh HR, 2016, 'Comparison of characteristics of methamphetamine versus opiate users in Tehran, Iran', International Journal of High Risk Behaviors and Addiction, vol. 5, http://dx.doi.org/10.5812/ijhrba.28815
Edge CL; King EJ; Dolan K; McKee M, 2016, 'Prisoners co-infected with tuberculosis and HIV: A systematic review: A', Journal of the International AIDS Society, vol. 19, http://dx.doi.org/10.7448/IAS.19.1.20960
Alammehrjerdi Z; Moradi A; Fenglian X; Zarghami M; Salehi-Fadardi J; Dolan K, 2016, 'Willingness to receive treatment for hepatitis c among injecting drug users on methadone program: Implications for education and treatment', Addiction and Health, vol. 8, pp. 1 - 8, http://ahj.kmu.ac.ir/index.php/ahj/article/view/384
Alam-Mehrjerdi Z; Moradi A; Xu F; Zarghami M; Salehi-Fadardi J; Dolan K, 2016, 'Willingness to Receive Treatment for Hepatitis C among Injecting Drug Users on Methadone Program: Implications for Education and Treatment.', Addict Health, vol. 8, pp. 90 - 97, https://www.ncbi.nlm.nih.gov/pubmed/27882206
Alammehrjerdi Z; Ezard N; Clare P; Dolan K, 2016, 'Brief Cognitive-Behavioural Therapy for Methamphetamine Use among Methadone-Maintained Women: A Multicentre Randomised Controlled Trial', Journal of Addiction Research & Therapy, vol. 7, pp. 1 - 8, http://dx.doi.org/10.4172/2155-6105.1000294
Dolan K; Worth H; Wilson D, 2015, 'Compulsory treatment of drug users in Asia: Designed to torture?', International Journal of Prisoner Health, vol. 11, pp. 255 - 268, http://dx.doi.org/10.1108/IJPH-09-2014-0030
Larney S; Zador D; Sindicich N; Dolan K, 2015, 'PATIENT EXPERIENCES OF OPIOID SUBSTITUTION THERAPY IN PRISON: REASONS FOR SEEKING AND CEASING TREATMENT', DRUG AND ALCOHOL REVIEW, vol. 34, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000106&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Alavi M; Spelman T; Matthews GV; Haber PS; Day C; van Beek I; Walsh N; Yeung B; Bruneau J; Petoumenos K; Dolan K; Kaldor JM; Dore GJ; Hellard M; Grebely J; Marks P; Amin J; Doab A; Carroll T; Teutsch S; Li H; Oon A; Cameron B; Lloyd A; White P; Rawlinson W; Jacqueline Flynn ; Goy K; Nguyen O; von Bibra S; Ffrench R; McCaughan G; Madden A; Farrell G; Crofts N; Sievert W; Baker D; Jacka B; Pan Y; Shaw D; Sasadeusz J; Crawford D; Phung N; George J; Bloch M; Hughes B; Mollison L; Roberts S; Desmond P, 2015, 'Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C', International Journal of Drug Policy, vol. 26, pp. 976 - 983, http://dx.doi.org/10.1016/j.drugpo.2015.05.003
Ezard N; Hodge S; Dolan K, 2015, 'The development and evaluation of stimulant treatment programmes', Current Opinion in Psychiatry, vol. 28, pp. 280 - 285, http://dx.doi.org/10.1097/YCO.0000000000000173
Alam-mehrjerdi Z; Abdollahi M; Higgs P; Dolan K, 2015, 'Drug use treatment and harm reduction programs in Iran: A unique model of health in the most populated Persian Gulf country', Asian Journal of Psychiatry, vol. 16, pp. 78 - 83, http://dx.doi.org/10.1016/j.ajp.2015.06.002
Alam-mehrjerdi Z; Mokri A; Dolan K, 2015, 'Methamphetamine use and treatment in Iran: A systematic review from the most populated Persian Gulf country', Asian Journal of Psychiatry, vol. 16, pp. 17 - 25, http://dx.doi.org/10.1016/j.ajp.2015.05.036
Iversen J; Dolan K; Ezard N; Maher L, 2015, 'HIV and hepatitis C virus infection and risk behaviors among heterosexual, bisexual, and lesbian women who inject drugs in Australia', LGBT Health, vol. 2, pp. 127 - 134, http://dx.doi.org/10.1089/lgbt.2014.0116
Dolan K; Rodas A; Bode A, 2015, 'Drug and alcohol use and treatment for Australian Indigenous and non-Indigenous prisoners: Demand reduction strategies', International Journal of Prisoner Health, vol. 11, pp. 30 - 38, http://dx.doi.org/10.1108/IJPH-02-2014-0005
Dolan K; Moazen B; Noori A; Rahimzadeh S; Farzadfar F; Hariga F, 2015, 'People who inject drugs in prison: HIV prevalence, transmission and prevention', International Journal of Drug Policy, vol. 26, pp. S12 - S15, http://dx.doi.org/10.1016/j.drugpo.2014.10.012
Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F; Dolan K; Haber P; Rawlinson W; Treloar C; Dore G; Maher L, 2015, 'Transmitted/founder viruses rapidly escape from CD8+ T cell responses in acute hepatitis C virus infection', Journal of Virology, vol. 89, pp. 5478 - 5490, http://dx.doi.org/10.1128/JVI.03717-14
Strathdee SA; West BS; Reed E; Moazan B; Azim T; Dolan K, 2015, 'Substance use and HIV among female sex workers and female prisoners: Risk environments and implications for prevention, treatment, and policies', Journal of Acquired Immune Deficiency Syndromes, vol. 69, pp. S110 - S117, http://dx.doi.org/10.1097/QAI.0000000000000624
Treloar C; McCredie L; Lloyd AR, 2015, 'Acquiring hepatitis C in prison: the social organisation of injecting risk', Harm Reduction Journal, vol. 12, http://dx.doi.org/10.1186/s12954-015-0045-2
Bretaña N; Boelen L; Bull R; Teutsch S; White P; Lloyd A; Luciani F, 2015, 'Transmission of Hepatitis C Virus among Prisoners, Australia, 2005–2012.', Emerging Infectious Diseases, vol. 21, pp. 765 - 774, http://dx.doi.org/10.3201/eid2105.141832
Alam-mehrjerdi Z; Noori R; Dolan K, 2014, 'Opioid use, treatment and harm reduction services: the first report from the Persian Gulf region', Journal of Substance Use, http://dx.doi.org/10.3109/14659891.2014.966344
Hajarizadeh B; Grebely J; Applegate T; Matthews GV; Amin J; Petoumenos K; Hellard M; Rawlinson W; Lloyd A; Kaldor J; Dore GJ, 2014, 'Dynamics of HCV RNA Levels During Acute Hepatitis C Virus Infection', Journal of Medical Virology, vol. 86, pp. 1722 - 1729, http://dx.doi.org/10.1002/jmv.24010
Luciani F; Bretaña NAR; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR, 2014, 'A prospective study of hepatitis C incidence in Australian prisoners', Addiction (Abingdon, England), vol. 109, pp. 1695 - 1706, http://dx.doi.org/10.1111/add.12643
Luciani F; Bretaña NAR; Teutsch S; Amin J; Topp L; Dore GJ; Maher L; Dolan K; Lloyd AR, 2014, 'A prospective study of hepatitis C incidence in Australian prisoners', Addiction (Abingdon, England), vol. 109, pp. 1695 - 1706, http://dx.doi.org/10.1111/add.12643
Boelen L; Teutsch S; Wilson DP; Dolan K; Dore GJ; Lloyd AR; Luciani F, 2014, 'Per-event probability of hepatitis C infection during sharing of injecting equipment', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0100749
Dolan K; Rodas A, 2014, 'Detection of drugs in Australian prisons: Supply reduction strategies', International Journal of Prisoner Health, vol. 10, pp. 111 - 117, http://dx.doi.org/10.1108/IJPH-06-2013-0025
Sugden PB; Cameron B; Mina M; Lloyd AR, 2014, 'Protection against hepatitis C infection via NK cells in highly-exposed uninfected injecting drug users', Journal of Hepatology, vol. 61, pp. 738 - 745, http://dx.doi.org/10.1016/j.jhep.2014.05.013
Flynn JK; Dore GJ; Hellard M; Yeung B; Rawlinson WD; White PA; Kaldor JM; Lloyd AR; Ffrench RA, 2013, 'Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment', Journal of Gastroenterology and Hepatology (Australia), vol. 28, pp. 1770 - 1781, http://dx.doi.org/10.1111/jgh.12265
Cameron B; Galbraith S; Li H; Lloyd A; HITS investigators , 2013, 'Correlates and characteristics of hepatitis C virus-specific T-cell immunity in exposed uninfected high-risk prison inmates', Journal of Viral Hepatitis, vol. 20, pp. e96 - e106, http://dx.doi.org/10.1111/jvh.12016
Grebely J; Alavi M; Spelman T; Haber P; Day C; Matthews G; Van Beek I; Walsh N; Yeung B; Petoumenos K; Dolan K; Kaldor J; Dore G; Hellard M, 2012, 'IMPACT OF TREATMENT OF RECENTLY-ACQUIRED HEPATITIS C INFECTION ON INJECTING DRUG USE BEHAVIOURS', DRUG AND ALCOHOL REVIEW, vol. 31, pp. 34 - 34, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Mccredie L; Luciani F; Teutsch S; Amin J; Topp L; Dolan K; Lloyd A, 2012, 'BLOODY PRISONS: INCIDENCE OF RISK BEHAVIOURS AND HEPATITIS C VIRUS TRANSMISSION IN AN AUSTRALIAN PRISONER COHORT', DRUG AND ALCOHOL REVIEW, vol. 31, pp. 57 - 57, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000311236700175&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Larney S; Toson B; Burns L; Dolan K, 2012, 'Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration', Addiction, vol. 107, pp. 372 - 380, http://dx.doi.org/10.1111/j.1360-0443.2011.03618.x
Larney S; Toson B; Burns LA; Dolan K, 2012, 'Effect of prison-based opioid substitution treatment and post-release retention in treatment on risk of re-incarceration', Addiction, vol. 107, pp. 372 - 380, http://dx.doi.org/10.1111/j.1360-0443.2011.03618.x/pdf
Grebely J; Matthews GV; Petoumenos K; Yeung B; Day C; Lloyd AR; Beek IV; Kaldor JM; Hellard M; Dore GJ; Haber PS; Alavi M, 2012, 'Effect of pegylated interferon-a-2a treatment on mental health during recent hepatitis C virus infection', Journal of Gastroenterology and Hepatology, vol. 27, pp. 957 - 965, http://dx.doi.org/10.1111/j.1440-1746.2011.07035.x
Grebely J; Pham ST; Matthews G; Petoumenos K; Bull RA; Yeung B; Rawlinson WD; Kaldor JM; Lloyd AR; Hellard M; Dore GJ; White PA; Bull , 2012, 'Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection', Hepatology, vol. 55, pp. 1058 - 1069, http://dx.doi.org/10.1002/hep.24754
Flynn J; Dore GJ; Matthews G; Hellard M; Yeung B; Rawlinson W; White PA; Kaldor JM; Lloyd AR; Ffrench RA, 2012, 'Impaired hepatitis C virus (HCV)-specific interferon-responses in individuals with HIV who acquire HCV infection: Correlation with CD4 + T-cell counts', Journal of Infectious Diseases, vol. 206, pp. 1568 - 1576, http://dx.doi.org/10.1093/infdis/jis544
Grebely J; Hellard M; Applegate TL; Petoumenos K; Yeung B; Feld J; Rawlinson WD; Lloyd AR; George J; Kaldor JM; Dore GJ; Matthews G, 2012, 'Virological responses during treatment for recent hepatitis C virus: Potential benefit for ribavirin use in HCV/HIV co-infection', AIDS, vol. 26, pp. 1653 - 1661, http://dx.doi.org/10.1097/QAD.0b013e3283553719
Gargari SS; Fallahian M; Haghighi L; Hosseinnezhad-Yazdi M; Dashti E; Dolan K, 2012, 'Maternal and neonatal complications of substance abuse in Iranian pregnant women', Acta Medica Iranica, vol. 50, pp. 411 - 416, http://journals.tums.ac.ir/upload_files/pdf/_/21203.pdf
Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Allsop D; Mokri A, 2012, 'Six-month follow-up of Iranian women in methadone treatment: Drug use, social functioning, crime, and HIV and HCV seroincidence', Susbtance Abuse and Rehabilitation, vol. 3, pp. 37 - 43, http://dx.doi.org/10.2147/SAR.S21349
Larney S; Toson B; Burns L; Dolan K, 2011, 'RE-INCARCERATION FOLLOWING PRISON-BASED OPIOID SUBSTITUTION TREATMENT', DRUG AND ALCOHOL REVIEW, vol. 30, pp. 52 - 52, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000297019700159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Dolan K, 2011, 'Do women and men know different things? Measuring gender differences in political knowledge', Journal of Politics, vol. 73, pp. 97 - 107, http://dx.doi.org/10.1017/S0022381610000897
Grebely J; Matthews G; Hellard M; Shaw D; van Beek I; Petoumenos K; Alavi M; Yeung B; Haber P; Lloyd AR; Kaldor JM; Dore GJ, 2011, 'Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users', Journal of Hepatology, vol. 55, pp. 76 - 85, http://dx.doi.org/10.1016/j.jhep.2010.10.033
Flynn JK; Dore GJ; Hellard M; Yeung B; Rawlinson WD; White PA; Kaldor JM; Lloyd AR; Ffrench RA, 2011, 'Early IL-10 predominant responses are associated with progression from acute to chronic hepatitis C virus infection in injecting drug users', Journal of Viral Hepatitis, vol. 18, pp. 549 - 561, http://dx.doi.org/10.1111/j.1365-2893.2010.01335.x
Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Allsop D; Mokri A, 2011, 'Characteristics of Iranian women seeking drug treatment', Journal of Women's Health, vol. 20, pp. 1687 - 1691, http://dx.doi.org/10.1089/jwh.2010.2694
Dolan K; Salimi S; Nassirimanesh B; Mohsenifar S; Mokri A, 2011, 'The establishment of a methadone treatment clinic for women in Tehran, Iran', Journal of Public Health Policy, vol. 32, pp. 219 - 230, http://dx.doi.org/10.1057/jphp.2011.10
Grebely J; Petoumenos K; Hellard M; Matthews G; Suppiah V; Applegate TL; Yeung B; Marks P; Rawlinson WD; Lloyd AROLA; Booth D; Kaldor JM; George J; Dore GJ, 2010, 'Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus Infection', Hepatology, vol. 52, pp. 1216 - 1224, http://dx.doi.org/10.1002/hep.23850
Grebely J; Petoumenos K; Matthews G; Haber PS; Marks P; Lloyd AROLA; Kaldor JM; Dore GJ; Hellard M; Dolan K, 2010, 'Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study', Drug and Alcohol Dependence, vol. 107, pp. 244 - 249, http://dx.doi.org/10.1016/j.drugalcdep.2009.09.015
Dore GJ; Hellard M; Matthews G; Grebely J; Haber PS; Petoumenos K; Yeung B; Marks P; Van Beek IA; McCaughan G; White PA; French R; Rawlinson WD; Lloyd AROLA; Kaldor JM; Dolan K, 2010, 'Effective treatment of injecting drug users with recently acquired hepatitis C virus infection', Gastroenterology, vol. 138, pp. 123 - 135, http://dx.doi.org/10.1053/j.gastro.2009.09.019
Teutsch S; Luciani F; Scheuer N; McCredie L; Hosseiny P; Rawlinson WD; Kaldor JM; Dore GJ; Dolan K; Ffrench R; Lloyd AROLA; Haber P; Levy MH, 2010, 'Incidence of primary Hepatitis C infection and risk factors for transmission in an Australian prisoner cohort', BMC Public Health, vol. 10, pp. 1 - 9, http://dx.doi.org/10.1186/1471-2458-10-633
Dolan K; Teutsch S; Scheuer N; Levy M; Rawlinson WD; Kaldor JM; Lloyd AROLA; Haber P, 2010, 'Incidence and risk for acute hepatitis C infection during imprisonment in Australia', European Journal of Epidemiology, vol. 25, pp. 143 - 148, http://dx.doi.org/10.1007/s10654-009-9421-0
Dolan K; Larney S, 2010, 'HIV in Indian prisons: Risk behaviour, prevalence, prevention and treatment', Indian Journal of Medical Research, vol. 132, pp. 696 - 700
Larney S; Dolan K, 2010, 'Compulsory detoxification is a major challenge to harm reduction in China', International Journal of Drug Policy, vol. 21, pp. 165 - 166, http://dx.doi.org/10.1016/j.drugpo.2009.05.001
Dolan K, 2009, 'Commentary: Prison research', Addiction, vol. 104, pp. 223 - 223
Matthews G; Hellard M; Haber P; Yeung B; Marks PB; Baker D; McCaughan G; Sasadeusz J; White PA; Rawlinson WD; Lloyd AR; Kaldor JM; Dore GJ, 2009, 'Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in acute hepatitis C', Clinical Infectious Diseases, vol. 48, pp. 650 - 658, http://dx.doi.org/10.1086/596770
Thomson N; Reid G; Dolan K, 2009, 'Examining HIV, drug use and risk behaviours: A case study in the custodial settings of Thailand and Indonesia', International Journal of Prisoner Health, vol. 5, pp. 180 - 191, http://dx.doi.org/10.1080/17449200903343118
Dolan K; Larney S; Jacka B; Rawlinson WD, 2009, 'Presence of hepatitis C virus in syringes confiscated in prisons in Australia', Journal of Gastroenterology and Hepatology, vol. 24, pp. 1655 - 1657, http://dx.doi.org/10.1111/j.1440-1746.2009.05978.x
Dolan K; Larney S, 2009, 'A review of HIV in prisons in Nepal', Kathmandu University Medical Journal, vol. 7, pp. 351 - 354, http://www.kumi.com.np/
Larney S; Dolan K, 2009, 'A literature review of international implementation of opioid subsitution treatment in prisons: Equivalence of care?', European Addiction Research, vol. 15, pp. 107 - 112, http://dx.doi.org/10.1159/000199046
Dolan K, 2009, 'Prison research', Addiction, vol. 104, pp. 223, http://dx.doi.org/10.1111/j.1360-0443.2008.02489.x
Dolan K, 2009, 'PRISON RESEARCH - Commentary', Addiction, vol. 104, pp. 223 - 223, http://dx.doi.org/10.1111/j.1360-0443.2008.02489.x
O Brien SM; Day C; Black E; Dolan K, 2008, 'Injecting drug users` understanding of hepatitis C', Addictive Behaviors, vol. 33, pp. 1602 - 1605, http://dx.doi.org/10.1016/j.addbeh.2008.07.005
Conroy EJ; Kimber J; Dolan K; Day CA, 2008, 'An examination of the quality of life among rural and outer metropolitan injecting drug users in NSW, Australia', Addiction Research and Theory, vol. 16, pp. 607 - 617, http://dx.doi.org/10.1080/16066350801911948
Larney S; Dolan K, 2008, 'An exploratory study of needlestick injuries among Australian prison officers', International Journal of Prisoner Health, vol. 4, pp. 164 - 168, http://dx.doi.org/10.1080/17449200802264720
Larney S; Dolan K, 2008, 'Increased access to opioid substitution treatment in prisons is needed to ensure equivalence of care', Australian and New Zealand Journal of Public Health, vol. 32, pp. 86 - 87, http://dx.doi.org/10.1111/j.1753-6405.2008.00172.x
Dolan K; Larney S; Wodak AD, 2007, 'The integration of harm reduction into abstinence-based therapeutic communities: A case study of We Help Ourselves.', ASIAN JOURNAL OF COUNSELLING, vol. 14, pp. 1 - 19
Razali K; Thein H; Bell J; Cooper-Stanbury M; Dolan K; Dore G; George J; Kaldor J; Karvelas M; Li J; Maher L; McGregor S; Hellard M; Poeder F; Quaine J; Stewart K; Tyrrell H; Weltman M; Westcott O; Wodak A; Law M, 2007, 'Modelling the hepatitis C virus epidemic in Australia', Drug and Alcohol Dependence, vol. 91, pp. 228 - 235, http://dx.doi.org/10.1016/j.drugalcdep.2007.05.026
Nguyen O; Dore GJ; Kaldor JM; Hellard M, 2007, 'Recruitment and follow-up of injecting drug users in the setting of early hepatitis C treatment: Insights from the ATAHC study', International Journal of Drug Policy, vol. 18, pp. 447 - 451, http://dx.doi.org/10.1016/j.drugpo.2007.01.007
Shearer J; Wodak AD; Dolan K, 2007, 'Evaluation of a prison-based naltrexone program', International Journal of Prisoner Health, vol. 3, pp. 214 - 224, http://dx.doi.org/10.1080/17449200701520149
Dolan K; Kite B; Black E; Aceijas C; Stimson G, 2007, 'HIV in prison in low-income and middle-income countries', Lancet Infectious Diseases, vol. 7, pp. 32 - 41, http://dx.doi.org/10.1016/S1473-3099(06)70685-5
Kimber J; Dolan K, 2007, 'Shooting Gallery Operation in the Context of Establishing a Medically Supervised Injecting Center: Sydney, Australia', Journal of Urban Health - Bulletin of the New York Academy of Medicine, vol. 84, pp. 255 - 266, http://dx.doi.org/10.1007/s11524-006-9145-3
Haber PS; Cameron BA; Elliott LN; Teutsch S; Ffrench R; Dolan K; Rawlinson B; Levy MH; Kaldor JM; Lloyd AR, 2007, 'Correlates of incident HCV infection and seronegative-immune status in high risk, IDU prisoners', Hepatology, vol. 46, pp. 630A - 630A, http://dx.doi.org/10.1002/hep.21931
Day CA; Dolan K, 2006, 'Correlates of hepatitis C testing among heroin users in Sydney.', Health Promotion Journal of Australia, vol. 17, pp. 70 - 72
Shearer J; White BA; Gilmour S; Wodak AD; Dolan K, 2006, 'Hair analysis underestimates heroin use in prisoners', Drug and Alcohol Review, vol. 25, pp. 425 - 431, http://dx.doi.org/10.1080/09595230600868512
Day CA; Conroy EJ; Lowe J; Page J; Dolan K, 2006, 'Patterns of drug use and assoiciated harms among rural injecting drug users: Comparisons with metropolitan injecting drug users', Australian Journal of Rural Health, vol. 14, pp. 120 - 125, http://dx.doi.org/10.1111/j.1440-1584.2006.00775.x
Day CA; Nassirimanesh B; Shakeshaft AP; Dolan K, 2006, 'Patterns of drug use among a sample of drug users and injecting drug users attending a General Practice in Iran', Harm Reduction Journal, vol. 3, http://dx.doi.org/10.1186/1477-7517-3-2
Warren EF; Viney R; Shearer J; Shanahan MD; Wodak AD; Dolan K, 2006, 'Value for money in drug treatment: economic evaluation of prison methadone', Drug and Alcohol Dependence, vol. 84, pp. 160 - 166, http://dx.doi.org/10.1016/j.drugalcdep.2006.01.010
Kaufman HL; DeRaffele G; Mitcham J; Moroziewicz D; Cohen SM; Hurst-Wicker KS; Cheung K; Lee DS; Divito J; Voulo M; Donovan J; Dolan K; Manson K; Panicali D; Wang E; Hörig H; Marincola FM, 2005, 'Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma', Journal of Clinical Investigation, vol. 115, pp. 1903 - 1912, http://dx.doi.org/10.1172/JCI24624
Day CA; Ross JE; Dietze P; Dolan K, 2005, 'Initiation to heroin injecting among heroin users in Sydney, Australia: cross-sectional survey.', Harm Reduction Journal, vol. 2, http://dx.doi.org/10.1186/1477-7517-2-2
Dolan K; Shearer J; White BA; Zhou J; Kaldor JM; Wodak AD, 2005, 'Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection', Addiction, vol. 100, pp. 820 - 828, http://dx.doi.org/10.1111/j.1360-0443.2005.01050.x
Day CA; Dolan K, 2005, 'Correlates of hepatitis C testing among heroin injectors in Sydeny', Health Promotion Journal of Australia, vol. 16, pp. 70 - 73
Shakeshaft AP; Nnassirimanesh B; Day CA; Dolan K, 2005, 'Perceptions of substance use, treatment options and training needs among Iranian primary care physicians.', International Journal for Equity in Health, vol. 4, http://dx.doi.org/10.1186/1475-9276-4-7
Southgate E; Weatherall A; Day CA; Dolan K, 2005, 'What¿s in a virus? Folk understandings of hepatitis C infection and infectiousness among injecting drug users in Kings Cross, Sydney.', International Journal for Equity in Health, vol. 4, http://dx.doi.org/10.1186/1475-9276-4-5
Dolan K; Niven H, 2005, 'A review of HIV prevention among young injecting drug users: A guide for researchers', Harm Reduction Journal, vol. 2, http://dx.doi.org/10.1186/1477-7517-2-5
Kimber J; Dolan K; Wodak AD, 2005, 'Survey of drug consumption rooms: service delivery and perceived public health and amenity impact', Drug and Alcohol Review, vol. 24, pp. 21 - 24, http://dx.doi.org/10.1080/09595230500125047
Stafford JA; Post JJ; Kaldor JM; Pan Y; Haber P; Lloyd AR; Dolan K, 2004, 'Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study Cohort, Australia', Journal of Urban Health - Bulletin of the New York Academy of Medicine, vol. 81, pp. 448 - 452, http://dx.doi.org/10.1093/jurban/jth129
Post JJ; Pan Y; Freeman AJ; Harvey CE; White PA; Palladinetti P; Haber P; Marinos G; Levy MH; Kaldor JM; Dolan K; Ffrench R; Lloyd AR; Rawlinson WD, 2004, 'Clearance of Hepatitis C Viremia Associated with Cellular Immunity in the Absence of Seroconversion in the Hepatitis C Incidence and Transmission in Prisons Study Cohort', Journal of Infectious Diseases, vol. 189, pp. 1846 - 1855, http://dx.doi.org/10.1086/383279
Dolan K; Clement N; Rouen DA; Rees V; Shearer J, 2004, 'Can drug injectors be encouraged to adopt non-injecting rouwtes of administration (NIROA) for drugs?', Drug and Alcohol Review, vol. 23, pp. 281 - 286, http://dx.doi.org/10.1080/09595230412331289437
Dolan K; Lowe D; Shearer J, 2004, 'Evaluation of the Condom Distribution Program in New South Wales Prisons, Australia', Journal of Law Medicine and Ethics, vol. 32, pp. 124 - 128, http://dx.doi.org/10.1111/j.1748-720X.2004.tb00457.x
Dolan K; Rouen DA; Kimber J, 2004, 'An overview of the use of urine, hair, sweat and saliva to detect drug use', Drug and Alcohol Review, vol. 23, pp. 213 - 217, http://dx.doi.org/10.1080/09595230410001704208
Dolan K; Bijl M; White BA, 2004, 'HIV education in a Siberian prison colony for drug dependent males', International Journal for Equity in Health, vol. 3, pp. 3 - 7, http://dx.doi.org/10.1186/1475-9276-3-7
Dolan KA; Davis PW, 2003, 'Nuances and shifts in lesbian women's constructions of STI and HIV vulnerability', Social Science and Medicine, vol. 57, pp. 25 - 38, http://dx.doi.org/10.1016/S0277-9536(02)00305-2
Day C; Ross J; Dolan K, 2003, 'Hepatitis C-related discrimination among heroin users in Sydney: Drug user or hepatitis C discrimination?', Drug and Alcohol Review, vol. 22, pp. 317 - 321, http://dx.doi.org/10.1080/0959523031000154463
Dolan K; Rouen DA, 2003, 'Evaluation of an Educational Comic on Harm Reduction for Prison Inmates in New South wales', International Journal of Forensic Psychiatry, vol. 1, pp. 138 - 141
Day CA; White BA; Ross JE; Dolan K, 2003, 'Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney', Australian and New Zealand Journal of Public Health, vol. 27, pp. 558 - 558
Day CA; Ross JE; Spooner CJ, 2003, 'Characteristics of Aboriginal Injecting Drug Users in Sydney Australia: Prison history, Hepatitis C status and drug treatment experiences', Journal of Ethnicity in Substance Abuse, vol. 2, pp. 51 - 58, http://dx.doi.org/10.1300/J233v02n03_03
Day CA; White BA; Ross JE; Dolan K, 2003, 'Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney', Australian and New Zealand Journal of Public Health, vol. 27, pp. 558 - 558
Dolan K; Rutter S; Wodak AD, 2003, 'Prison-based syringe exchange programmes: a review of international research and development', Addiction, vol. 98, pp. 153 - 158, http://dx.doi.org/10.1046/j.1360-0443.2003.00309.x
O Sullivan BG; Levy MH; Dolan K; Post JJ; Barton SG; Dwyer D; Kaldor JM; Grulich AE, 2003, 'Hepatitis C transmission and HIV post-exposure prophylaxis after needle-and syringe-sharing in Australian prisons', Medical Journal of Australia, vol. 178, pp. 546 - 549
Dolan K; Shearer J; MacDonald MA; Mattick RP; Hall WD; Wodak AD, 2003, 'A randomized controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system', Drug and Alcohol Dependence, vol. 72, pp. 59 - 65, http://dx.doi.org/10.1016/S0376-8716(03)00187-X
Day CA; Topp LJ; Rouen DA; Darke S; Hall WD; Dolan K, 2003, 'Decreased heroin availability in Sydney in early 2001', Addiction, vol. 98, pp. 93 - 95, http://dx.doi.org/10.1046/j.1360-0443.2003.00266.x
Law MG; Dore GJ; Bath N; Thompson S; Crofts N; Dolan K; Giles W; Gow P; Kaldor JM; Loveday S; Powell E; Spencer J; Wodak AD, 2003, 'Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001', International Journal of Epidemiology, vol. 32, pp. 717 - 724, http://dx.doi.org/10.1093/ije/dyg101
Kimber J; Dolan K; Van Beek IA; Hedrich D, 2003, 'Drug consumption facilities: an update since 2000', Drug and Alcohol Review, vol. 22, pp. 227 - 233, http://dx.doi.org/10.1080/095952301000116951
Butler TG; Levy MH; Dolan K; Kaldor JM, 2003, 'Drug use and its correlates in an Australian prison population', Addiction Research and Theory, vol. 11, pp. 89 - 101, http://dx.doi.org/10.1080/1606635021000021403
Rouen D; Dolan K, 2001, 'Supporting needle and syringe programs in Australia', Australian and New Zealand Journal of Public Health, vol. 25, pp. 187, http://dx.doi.org/10.1111/j.1753-6405.2001.tb01845.x
Shearer J; Wodak AD; Mattick RP; Van Beek IA; Lewis J; Hall WD; Dolan K, 2001, 'Pilot randomized controlled study of dexamphetamine substitution for amphetamine dependence', Addiction, vol. 96, pp. 1289 - 1296, http://dx.doi.org/10.1046/j.1360-0443.2001.96912898.x
Dolan K, 2001, 'Can hepatitis C transmission be reduced in Australian prisons', Medical Journal of Australia, vol. 174, pp. 378 - 379
Post JJ; Dolan K; Whybin R; Carter I; Haber P; Lloyd AR, 2001, 'Acute hepatitis C virus infection in an Australian prison inmate: tattooing as a possible transmission route', Medical Journal of Australia, vol. 174, pp. 183 - 184
Kimber J; Dolan K, 2001, 'Starting and managing needle and syringe programs: a guide for Central and Eastern Europe and the newly independent states of the former Soviet Union', International Journal of Drug Policy, vol. 12, pp. 203 - 203, http://dx.doi.org/10.1016/s0955-3959(01)00084-6
Macdonald MA; Wodak AD; Dolan KA, 2000, 'Erratum: Hepatitis C antibody prevalence among injecting drug users at selected needle and syringe exchange programs in Australia 1995-1997 (Medical Journal of Australia (2000) 172 (57-61))', Medical Journal of Australia, vol. 172, pp. 277
Dolan K; Kimber J; Fry C; Fitzgerald J; Mcdonald D; Trautmann F, 2000, 'Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia', Drug and Alcohol Review, vol. 19, pp. 337 - 346, http://dx.doi.org/10.1080/713659379
Dolan K, 2000, 'Surveillance and prevention of hepatitis C in Australian prisons.', Canadian HIV-AIDS policy & law newsletter / Canadian HIV-AIDS Legal Network = Réseau juridique canadien VIH-SIDA, vol. 5, pp. 68 - 69
MacDonald MA; Wodak AD; Dolan K; Van Beek IA; Cunningham PH; Kaldor JM, 2000, 'Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997', Medical Journal of Australia, vol. 172, pp. 57 - 61
Dolan K; Wodak AD, 1999, 'HIV transmission in a prison system in an Australian State', Medical Journal of Australia, vol. 171, pp. 14 - 17
Dolan K; Wodak AD; Hall WD, 1999, 'HIV risk behaviour and prevention in prison: a bleach programme for inamtes in NSW', Drug and Alcohol Review, vol. 18, pp. 139 - 143, http://dx.doi.org/10.1080/09595239996563
Byrne A; Dolan K, 1998, 'Methadone treatment is widely accepted in prisons in New South Wales [3]', British Medical Journal, vol. 316, pp. 1744 - 1745
Dolan K; Wodak AD; Hall WD, 1998, 'Methadone maintenance treatment reduces heroin injection in New South Wales prisons', Drug and Alcohol Review, vol. 17, pp. 153 - 158, http://dx.doi.org/10.1080/09595239800186951
Dolan K; Wodak AD; Hall WD; Kaplan E, 1998, 'A mathematical model of HIV transmission in NSW prisons', Drug and Alcohol Dependence, vol. 50, pp. 197 - 202, http://dx.doi.org/10.1016/S0376-8716(98)00009-X
Dolan K; Wodak AD; Hall WD, 1998, 'A bleach program for inmates in NSW: an HIV prevention strategy', Australian and New Zealand Journal of Public Health, vol. 22, pp. 838 - 840
Dolan K, 1997, 'Evidence about HIV transmission in prisons.', Canadian HIV-AIDS policy & law newsletter / Canadian HIV-AIDS Legal Network = Réseau juridique canadien VIH-SIDA, vol. 3-4, pp. 32 - 38
Dolan K; Ford LE, 1997, 'Change and continuity among women state legislators: Evidence from three decades', Political Research Quarterly, vol. 50, pp. 137 - 151, http://dx.doi.org/10.1177/106591299705000107
Dolan K, 1997, 'Gender differences in support for women candidates: Is there a glass ceiling in American politics?', Women and Politics, vol. 17, pp. 27 - 41, http://dx.doi.org/10.1300/J014v17n02_02
Dolan K, 1997, 'AIDS, drugs and risk behaviour in prison: State of the art', International Journal of Drug Policy, pp. 5 - 17
MacDonald MA; Wodak AD; Ali RL; Crofts N; Cunningham PH; Dolan K; Kelaher M; Loxley W; Van Beek IA; Kaldor JM, 1997, 'HIV prevalence and risk behaviour in needle exchange attenders- a national study', Medical Journal of Australia, vol. 166, pp. 237 - 240
Butler T; Dolan K; Ferson MJ; Mcguiness L; Brown PJ; Robertson PW; Butler , 1997, 'Hepatitis B and C in New South Wales prisons. Prevalence and risk factors', Medical Journal of Australia, vol. 166, pp. 127 - 130
MacDonald MA; Wodak AD; Ali RL; Crofts N; Cunningham PH; Dolan K; Kelaher M; Loxley W; Van Beek IA; Kaldor JM, 1997, 'HIV prevalence and risk behaviour in need exchange attenders: a natinoal study', Medical Journal of Australia, vol. 166, pp. 237 - 240
Rutter S; Dolan K; Wodak AD, 1997, 'Rooms for ent: injecting and harm reduction in Sydney', Australian and New Zealand Journal of Public Health, vol. 21, pp. 105 - 105
Crofts N; Jolley D; Kaldor JM; Van Beek IA; Wodak AD, 1997, 'Epidemiology of hepatitis C virus infection among injecting drug users in Australia', Journal of Epidemiology and Community Health, vol. 51, pp. 692 - 697, http://dx.doi.org/10.1136/jech.51.6.692
Wodak A; Dolan K, 1996, 'Controlling an epidemic .8.5. HIV prevention in the community: Injecting drug users', MEDICAL JOURNAL OF AUSTRALIA, vol. 165, pp. 266 - 267, http://dx.doi.org/10.5694/j.1326-5377.1996.tb124963.x
Hall W; Dolan K, 1996, 'Is there a role for contact tracing in preventing HIV transmission among injecting drug users?', Addiction, vol. 91, pp. 917 - 919, http://dx.doi.org/10.1111/j.1360-0443.1996.tb03585.x
Dolan KA; Wodak AD; Rutter SA, 1996, 'Is a syringe exchange feasible in a prison setting? Reply', MEDICAL JOURNAL OF AUSTRALIA, vol. 165, pp. 59 - 59, http://dx.doi.org/10.5694/j.1326-5377.1996.tb124821.x
Dolan K; Hall W; Wodak A, 1996, 'Methadone maintenance reduces injecting in prison [13]', British Medical Journal, vol. 312, pp. 1162
Dolan K; Wodak A; Hall W; Gaughwin M; Rae F, 1996, 'HIV risk behaviour of IDUs before, during and after imprisonment in New South Wales', Addiction Research and Theory, vol. 4, pp. 151 - 160, http://dx.doi.org/10.3109/16066359609010754
Dolan K, 1996, 'Support for women political candidates: An examination of the role of family', Women and Politics, vol. 16, pp. 45 - 60, http://dx.doi.org/10.1300/J014v16n02_03
Dolan K; Wodak AD; Hall WD; Gaughwin M; Rae F, 1996, 'HIV risk behaviour of IDU`s before, during and after imprisonment in New South Wales', Addiction Research, pp. 155 - 160
Wodak AD; Dolan K, 1996, 'HIV prevention in the community:injecting drug users', Medical Journal of Australia, vol. 165, pp. 266 - 267
Dolan K; Rutter S; Wodak AD; Hall W; Maher L; Dixon D, 1996, 'Is syringe exchange feasible in a prison setting?', Medical Journal of Australia, vol. 164, pp. 508
Dolan K; Wodak AD, 1996, 'An international review of methadone provision in prison', Addiction Research, vol. 4, pp. 85 - 97
Dolan K, 1995, 'Attitudes, behaviors, and the influence of the family: A reexamination of the role of family structure', Political Behavior, vol. 17, pp. 251 - 264, http://dx.doi.org/10.1007/BF01498596
Ford LE; Dolan K, 1995, 'THE POLITICS OF WOMEN STATE LEGISLATORS: A SOUTH/NON‐SOUTH COMPARISON', Southeastern Political Review, vol. 23, pp. 333 - 348, http://dx.doi.org/10.1111/j.1747-1346.1995.tb00416.x
Dolan K; Ford LE, 1995, 'Women in the state legislatures: Feminist Identity and Legislative Behaviors', American Politics Research, vol. 23, pp. 96 - 108, http://dx.doi.org/10.1177/1532673X9502300105
Dolan K; Wodak AD; Penny R, 1995, 'AIDS behind bars: Preventing HIV spreas among incarcerated drug injectors', AIDS, vol. 9, pp. 825 - 832, http://dx.doi.org/10.1097/00002030-199508000-00001
WODAK AD; DOLAN KA, 1994, 'EVIDENCE OF HIV TRANSMISSION IN AN AUSTRALIAN PRISON - REPLY', MEDICAL JOURNAL OF AUSTRALIA, vol. 161, pp. 509 - 509, http://dx.doi.org/10.5694/j.1326-5377.1994.tb127575.x
Dolan K; Hall W; Wodak A; Gaughwin M, 1994, 'Evidence of HIV transmission in an Australian prison [6]', Medical Journal of Australia, vol. 160, pp. 734, http://dx.doi.org/10.5694/j.1326-5377.1994.tb125930.x
Turnbull PJ; Dolan KA; Stimson GV, 1993, 'HIV testing, and the care and treatment of HIV positive people in English prisons', AIDS Care, vol. 5, pp. 199 - 206, http://dx.doi.org/10.1080/09540129308258600
DOLAN KA; STIMSON GV; DONOGHOE MC, 1993, 'Reductions in HIV risk behaviour and stable HIV prevalence in syringe‐exchange clients and other injectors in England', Drug and Alcohol Review, vol. 12, pp. 133 - 142, http://dx.doi.org/10.1080/09595239300185561
Turnbull PJ; Stimson GV; Dolan KA, 1992, 'Prevalence of HIV infection among ex-prisoners in England', British Medical Journal, vol. 304, pp. 90 - 91, http://dx.doi.org/10.1136/bmj.304.6819.90
DONOGHOE MC; DOLAN KA; STIMSON GV, 1992, 'Life‐style factors and social circumstances of syringe sharing in injecting drug users', British Journal of Addiction, vol. 87, pp. 993 - 1003, http://dx.doi.org/10.1111/j.1360-0443.1992.tb03116.x
DOLAN KA; DONOGHOE MC; STIMSON GV, 1990, 'Drug Injecting and Syringe Sharing in Custody and in the Community: An Exploratory Survey of HIV Risk Behaviour', The Howard Journal of Criminal Justice, vol. 29, pp. 177 - 186, http://dx.doi.org/10.1111/j.1468-2311.1990.tb00679.x
Carlson JM; Burrell B; Dolan K, 1989, 'Ideology and campaign activity at three levels of government', Political Behavior, vol. 11, pp. 273 - 287, http://dx.doi.org/10.1007/BF00992300
Donoghoe MC; Stimson GV; Dolan KA, 1989, 'Sexual Behaviour of Injecting Drug Users and Associated Risks of HIV Infection for Non-injecting Sexual Partners', AIDS Care, vol. 1, pp. 51 - 58, http://dx.doi.org/10.1080/09540128908260235
1989, 'The Pilot Syringe‐Exchange Project in England and Scotland: a summary of the evaluation', British Journal of Addiction, vol. 84, pp. 1283 - 1284, http://dx.doi.org/10.1111/j.1360-0443.1989.tb00726.x
Donoghoe MC; Stimson GV; Dolan K; Alldritt L, 1989, 'Changes in HIV risk behaviour in clients of syringe-exchange schemes in England and Scotland', AIDS, vol. 3, pp. 267 - 272
Stimson G; Alldritt L; Dolan K; Donoghoe M, 1988, 'Preventing the spread of HIV in injecting drug users - The experience of syringe-exchange schemes in England and Scotland', NIDA Research Monograph Series, pp. 302 - 310
STIMSON GV; DONOGHOE M; DOLAN K; ALLDRITT L, 1988, 'A VOLATILE TIME FOR BRITISH DRUG POLICIES - COMMENTARY', BRITISH JOURNAL OF ADDICTION, vol. 83, pp. 1241 - 1242, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988R071100003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Stimson GV; Alldritt L; Dolan K; Donoghoe M, 1988, 'Syringe exchange schemes for drug users in England and Scotland', British Medical Journal (Clinical research ed.), vol. 296, pp. 1717 - 1719, http://dx.doi.org/10.1136/bmj.296.6638.1717
STIMSON GV; DONOGHOE M; DOLAN K; ALLDRITT L, 1988, 'A Volatile Time for British Drug Policies: commentary on the Editorial by Alan Glanz', British Journal of Addiction, vol. 83, pp. 1241 - 1242, http://dx.doi.org/10.1111/j.1360-0443.1988.tb03033.x
STIMSON GV; DONOGHOE M; ALLDRITT L; DOLAN K, 1988, 'HIV Transmission Risk Behaviour of Clients Attending Syringe‐exchange Schemes in England and Scotland', British Journal of Addiction, vol. 83, pp. 1449 - 1455, http://dx.doi.org/10.1111/j.1360-0443.1988.tb02559.x
Wodak A; Dolan K; Imrie AA; Gold J; Wolk J; Whyte BM; Cooper DA, 1987, 'Antibodies to the human immunodeficiency virus in needles and syringes used by intravenous drug abusers', Medical Journal of Australia, vol. 147, pp. 275 - 276, http://dx.doi.org/10.5694/j.1326-5377.1987.tb133453.x
Conference Papers
Ayyaz Z; Dolan K, 2017, 'NARCOTICS ARE CHEAPER THAN FOOD IN PAKISTAN: OUR PWIDS ARE DYING FROM AIDS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A231 - A232, http://dx.doi.org/10.1136/sextrans-2017-053264.604
Jose H; Rawstorne P; Rahman B; Dolan K, 2015, 'TIMOR-LESTE NATIONAL SIZE ESTIMATES AND BEHAVIOURAL DATA FOR KEY POPULATIONS AT RISK OF HIV AND OTHER STIS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A182 - A182, http://dx.doi.org/10.1136/sextrans-2015-052270.473
Grebely J; Alavi M; Haber P; Day C; Matthews GV; van Beek I; Walsh N; Yeung B; Petoumenos K; Dolan K; Spelman T; Kaldor JM; Dore GJ; Hellard M, 2011, 'IMPACT OF TREATMENT ON INJECTING DRUG USE BEHAVIORS DURING RECENT HCV INFECTION: THE ATAHC STUDY', in JOURNAL OF HEPATOLOGY, ELSEVIER, GERMANY, Berlin, pp. S174 - S174, presented at 46th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), GERMANY, Berlin, 30 March 2011 - 03 April 2011, http://dx.doi.org/10.1016/S0168-8278(11)60431-5
Lloyd AR; Cameron BA; Elliott LN; Galbraith SA; Li H; Teutsch S; Dolan K; Levy MT; Haber PS; Rawlinson WD; Kaldor JM; Ffrench R, 2008, 'Correlates of HCV seronegative-immune status in high risk IDU prison inmates', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A356 - A356, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600067&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Lloyd AR; Teutsch S; Scheuer N; Dolan K; McCredie L; Ffrench R; Levy MT; Haber PS; Rawlinson WD; Kaldor JM, 2008, 'Predictors of HCV incidence in IDU prison inmates', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A346 - A347, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Maher L; Dore G; Treloar C; Rawlinson W; White P; Dolan K; Zekry A; Madden A; Loveday S; Kaldor J; Lloyd A, 2008, 'Preparedness for candidate hepatitis C vaccine trials in people who inject drugs: challenges and opportunities', in Journal of Gastroenterology and Hepatology, Blackwell Publishing Asia, Carlton, Victoria, Australia, pp. A358 - A358, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000264953600072&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a
Hellard M; Dore G; Haber P; Marks P; Matthews G; Yeung B; Nguyen O; Pan Y; Ffrench R; McCaughan G; Van Beek I; White P; Dolan K; Rawlinson W; Lloyd A; Kaldor J, 2006, 'Australian trial in acute hepatitis C: preliminary findings', in JOURNAL OF CLINICAL VIROLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S139 - S139, presented at 12th International Symposium on Viral Hepatitis and Liver Disease, FRANCE, Paris, 01 July 2006 - 05 July 2006, http://dx.doi.org/10.1016/S1386-6532(06)80430-0
Hellard M; Haber P; Day C; Marks P; Matthews G; Yeung B; Nguyen O; Dolan K; Van Beek I; Kaldor J; Dore G, 2006, 'Australian trial in acute hepatitis C: baseline behavioural data', in JOURNAL OF CLINICAL VIROLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, pp. S140 - S140, presented at 12th International Symposium on Viral Hepatitis and Liver Disease, FRANCE, Paris, 01 July 2006 - 05 July 2006, http://dx.doi.org/10.1016/S1386-6532(06)80434-8
DOLAN K; JONES S; DONOGHOE M; STIMSON G, 1991, 'REDUCED SYRINGE SHARING AND LOW HIV RATES FOR SYRINGE EXCHANGE ATTENDERS AND OTHER ENGLISH INJECTORS', in BRITISH JOURNAL OF ADDICTION, CARFAX PUBL CO, pp. 1517 - 1517, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1991GQ30900034&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
TURNBULL P; DOLAN K; STIMSON G, 1991, 'DRUG-USE AND INJECTING, BEFORE, DURING AND AFTER IMPRISONMENT', in BRITISH JOURNAL OF ADDICTION, CARFAX PUBL CO, pp. 1516 - 1516, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1991GQ30900031&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
STIMSON GV; ALLDRITT L; DONOGHOE M; DOLAN K, 1988, 'REDUCING HIV-RELATED RISK BEHAVIOR - FOLLOW UP OF CLIENTS OF SYRINGE-EXCHANGE SCHEMES', in BRITISH JOURNAL OF ADDICTION, CARFAX PUBL CO, pp. 1476 - 1476, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1988R301400035&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
ALLDRITT L; DOLAN K; DONOGHOE M, 1987, 'HIV AND THE INJECTING DRUG USER .2. CLIENTS OF SYRINGE EXCHANGE SCHEMES', in BRITISH JOURNAL OF ADDICTION, CARFAX PUBL CO, pp. 1365 - 1365, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1987L398600019&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Conference Posters
Cunningham EB; Hajarizadeh B; Amin J; Betz-Stablein B; Dore GJ; Luciani F; Teutsch S; Bretana NA; Dolan K; Lloyd AR; Grebely J, 2018, 'A161 ONGOING INCIDENT HEPATITIC C VIRUS INFECTION AMONG PEOPLE WITH A HISTORY OF INJECTING DRUG USE IN AN AUSTRALIAN PRISON SETTING', in Journal of the Canadian Association of Gastroenterology, Oxford University Press (OUP), Vol. 1, pp. 278 - 280, http://dx.doi.org/10.1093/jcag/gwy008.162
Conference Abstracts
Ezard N; Dunlop AJ; Carr A; McKetin R; Ali R; White J; Bruno R; Dolan K; Clifford B; Lintzeris N, 2016, 'A RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF LISDEXAMFETAMINE FOR THE TREATMENT OF METHAMPHETAMINE DEPENDENCE: THE LIMA STUDY PROTOCOL', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 35 - 36, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000398381500097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Reports
Moazen B; Dolan K; Bosworth R; Owusu PN; Wiessner P; Stöver H, 2019, Availability, coverage and barriers towards condom provision in prisons: A review of the evidence, Institut für Suchtforschung (ISFF), Frankfurt University of Applied Sciences, Frankfurt, https://www.researchgate.net/publication/330543762_Availability_Coverage_and_Barriers_Towards_Condom_Provision_in_Prisons_A_Review_of_the_Evidence
Dolan K, 2018, The Accessibility and Availability of Fincol and Condoms as Harm Reduction Measures in NSW Prisons.
Dolan K; Alam Mehrjerdi Z, 2015, Medication-assisted treatment of opioid dependence a review of evidence, Australian National Council on Drugs, Canberra, ANCD research paper 32
Dolan K; Alam Mehrjerdi Z, 2015, Medication-assisted treatment of opioid dependence your questions answered, Australian National Council on Drugs, Canberra
Dolan K; Jose H; Rahman B; Rawstorne P, 2015, Population size estimation of female sex workers, men who have sex with men and people who use and inject drugs in Timor-Leste, National HIV/AIDS & STIs Control Programme of the Ministry of Health Timor-Leste, Dili, Timor-Leste, Final report April 2015
Dolan K; larney S, 2015, Patients motivations, perceptions and experiences of OST in prison report: Qualitative component
Rodas AA; Bode A; Dolan K, 2012, Supply, demand and harm reduction strategies in Australian prisons: an update, Australian National Council on Drugs, ACT, ANCD Research Paper, 23, http://www.ancd.org.au/images/PDF/Researchpapers/rp23_australian_prisons.pdf
Larney S; Dolan K, 2008, Demand reduction strategies in closed settings in China, Indonesia and Viet Nam, National Drug and Alcohol Research Centre, Sydney, 291, http://ndarc.med.unsw.edu.au/sites/all/shared_files/ndarc/resources/TR.291.pdf
Larney S; Morton P; Dolan K, 2007, HIV prevention, treatment and care in prisons in South-east Asia, National Drug and Alcohol Research Centre, Sydney, NSW, 290, http://ndarc.med.unsw.edu.au/sites/all/shared_files/ndarc/resources/TR.290.pdf
Larney S; Corcoran K; Wodak AD; Dolan K, 2006, The Integration of harm reduction into abstinence-based Therapeutic Communities: A Case Study of We Help Ourselves, National Drug and Alcohol Research Centre, Sydney, NSW, 263